Cargando…

Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3‐Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects

BACKGROUND: The ketone body 3‐hydroxybutyrate (3‐OHB) increases cardiac output (CO) in patients with heart failure through unknown mechanisms. 3‐OHB activates the hydroxycarboxylic acid receptor 2 (HCA(2)), which increases prostaglandins and suppresses circulating free fatty acids. We investigated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gopalasingam, Nigopan, Christensen, Kristian Hylleberg, Berg Hansen, Kristoffer, Nielsen, Roni, Johannsen, Mogens, Gormsen, Lars Christian, Boedtkjer, Ebbe, Nørregaard, Rikke, Møller, Niels, Wiggers, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356045/ https://www.ncbi.nlm.nih.gov/pubmed/37301762 http://dx.doi.org/10.1161/JAHA.123.029849

Ejemplares similares

Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension
por: Nielsen, Roni, et al.
Publicado: (2023)

Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility
por: Homilius, Casper, et al.
Publicado: (2023)

Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
por: Nielsen, Roni, et al.
Publicado: (2019)

Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
por: Gormsen, Lars C., et al.
Publicado: (2017)

β-hydroxybutyrate and hydroxycarboxylic acid receptor 2 agonists activate the AKT, ERK and AMPK pathways, which are involved in bovine neutrophil chemotaxis
por: Carretta, María D., et al.
Publicado: (2020)

D-ß-hydroxybutyrate: an anti-aging ketone body
por: Edwards, Clare, et al.
Publicado: (2015)

Ketone body 3-hydroxybutyrate as a biomarker of aggression
por: Whipp, A. M., et al.
Publicado: (2021)

Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator
por: McCarthy, Cameron G., et al.
Publicado: (2021)

Ketone body 3-hydroxybutyrate enhances adipocyte function
por: Nishitani, Shigeki, et al.
Publicado: (2022)

On the nutritional and therapeutic effects of ketone body d-β-hydroxybutyrate
por: Yao, Aliya, et al.
Publicado: (2021)

Ketone body β-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics
por: Llorente-Folch, I., et al.
Publicado: (2023)

Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-(11)C]β-hydroxybutyrate ([(11)C]OHB) PET in healthy humans
por: Luong, Thien Vinh, et al.
Publicado: (2023)

Disturbed acid-base transport: an emerging cause of hypertension
por: Boedtkjer, Ebbe, et al.
Publicado: (2013)

Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives
por: Ren, Qun, et al.
Publicado: (2010)

Chiroptical activity of hydroxycarboxylic acids with implications for the origin of biological homochirality
por: Bocková, Jana, et al.
Publicado: (2021)

Ketone Body β-Hydroxybutyrate Prevents Myocardial Oxidative Stress in Septic Cardiomyopathy
por: Ji, Liwei, et al.
Publicado: (2022)

Mechanism of reduced muscle atrophy via ketone body (D)-3-hydroxybutyrate
por: Chen, Jin, et al.
Publicado: (2022)

Investigating effects of sodium beta‐hydroxybutyrate on metabolism in placebo‐controlled, bilaterally infused human leg with focus on skeletal muscle protein dynamics
por: Thomsen, Henrik Holm, et al.
Publicado: (2022)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial
por: Svart, Mads, et al.
Publicado: (2018)

Production of Hydroxycarboxylic Acid Receptor 3 (HCA(3)) Ligands by Bifidobacterium
por: Sakurai, Takuma, et al.
Publicado: (2021)

Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease
por: Youm, Yun-Hee, et al.
Publicado: (2015)

Ketone body therapy with D/L-β-hydroxybutyric acid solution in severe MADD
por: Fischer, Tobias, et al.
Publicado: (2019)

Comparing Finger-stick β-Hydroxybutyrate with Dipstick Urine Tests in the Detection of Ketone Bodies
por: KURU, Baris, et al.
Publicado: (2016)

β hydroxybutyrate levels in serum and cerebrospinal fluid under ketone body metabolism in rats
por: Wang, Xiaomeng, et al.
Publicado: (2017)

Anti-Aging Effect of the Ketone Metabolite β-Hydroxybutyrate in Drosophila Intestinal Stem Cells
por: Park, Joung-Sun, et al.
Publicado: (2020)

Murine breast cancer feed arteries are thin-walled with reduced α(1A)-adrenoceptor expression and attenuated sympathetic vasocontraction
por: Froelunde, Anne Sofie, et al.
Publicado: (2018)

Acidosis inhibits rhythmic contractions of human thoracic ducts
por: Moeller, Anders L., et al.
Publicado: (2019)

Structural basis of hydroxycarboxylic acid receptor signaling mechanisms through ligand binding
por: Suzuki, Shota, et al.
Publicado: (2023)

Ketone body 3‐hydroxybutyrate mimics calorie restriction via the Nrf2 activator, fumarate, in the retina
por: Izuta, Yusuke, et al.
Publicado: (2017)

Effect of the Ketone Body Beta-Hydroxybutyrate on the Innate Defense Capability of Primary Bovine Mammary Epithelial Cells
por: Hillreiner, Maria, et al.
Publicado: (2016)

β-Hydroxybutyrate, a Ketone Body, Potentiates the Antioxidant Defense via Thioredoxin 1 Upregulation in Cardiomyocytes
por: Oka, Shin-ichi, et al.
Publicado: (2021)

Hydroxycarboxylic Acid Receptor 1 and Neuroprotection in a Mouse Model of Cerebral Ischemia-Reperfusion
por: Buscemi, Lara, et al.
Publicado: (2021)

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2
por: Cheng, Lin, et al.
Publicado: (2023)

Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2
por: Pan, Xin, et al.
Publicado: (2023)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate
por: Sleiman, Sama F, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a7r4ae15m99sgt88vkm4e9rs4j